{"title":"TyG index and progression of diabetic kidney disease in type 2 diabetes: A retrospective cohort study.","authors":"Wei Dong, Minjie Lin, Yunyao Chen","doi":"10.5414/CN112179","DOIUrl":"10.5414/CN112179","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the independent association between the triglyceride-glucose (TyG) index and diabetic kidney disease (DKD) progression in patients with type 2 diabetes mellitus (T2DM).</p><p><strong>Materials and methods: </strong>A retrospective study included a NHANES cohort (2003 - 2020, n = 4,086) and a clinical cohort (n = 535, median follow-up 36 months). Weighted logistic regression, Cox regression, restricted cubic splines, and ROC curves were used.</p><p><strong>Results: </strong>In the NHANES cohort, each 1-unit increase in the TyG index was associated with a 56.4% higher risk of prevalent DKD (OR = 1.56, 95% CI: 1.06 - 2.31). A linear positive association and a threshold of 8.19 were identified; above this, risk increased significantly (OR = 1.82). The association was significant in males (OR = 1.61) but not females. In the clinical cohort, a high TyG index (≥ 8.19) independently predicted DKD progression (HR = 1.53, 95% CI: 1.01 - 2.30). Kaplan-Meier curves showed significant differences across TyG groups (log-rank p < 0.001). The AUC for predicting progression was 0.71 (95% CI: 0.68 - 0.74). Sex-stratified analysis confirmed significance only in males (HR = 1.85).</p><p><strong>Conclusion: </strong>The TyG index shows a significant overall association with DKD progression, with a threshold effect at 8.19. Sex-stratified analysis revealed that this association was statistically significant only in male patients. These findings suggest that the TyG index may serve as a convenient and cost-effective early risk predictor for DKD, particularly in male diabetic patients. The observed sex heterogeneity warrants further investigation into the potential role of hormonal factors.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Autosomal dominant polycystic kidney disease with Caroli-like hepatic cystic lesions: A genetically confirmed family case series.","authors":"Gangyi Wang, Wenyuan Duan, Ping Chen","doi":"10.5414/CN112202","DOIUrl":"10.5414/CN112202","url":null,"abstract":"<p><strong>Aim: </strong>To describe a genetically confirmed family case series of autosomal dominant polycystic kidney disease (ADPKD) presenting with hepatic cystic lesions that mimicked Caroli disease and to highlight the diagnostic value of integrating imaging findings with molecular genetic testing.</p><p><strong>Materials and methods: </strong>A 36-year-old man with multiple hepatic and renal cysts and a positive family history of cystic kidney disease underwent comprehensive clinical evaluation, laboratory testing, abdominal ultrasonography, abdominal magnetic resonance imaging, and whole-exome sequencing. Clinical and genetic findings were assessed in affected family members.</p><p><strong>Results: </strong>Imaging demonstrated multiple hepatic cystic lesions with features suggestive of Caroli disease, together with bilateral renal cysts. Whole-exome sequencing identified a heterozygous pathogenic <i>PKD2</i> variant (c.2407C>T, p.Arg803*; rs778235410) in all affected family members, confirming the diagnosis of ADPKD type 2. The coexistence of polycystic liver disease and Caroli-like biliary abnormalities created a diagnostic challenge. Integration of family history, imaging findings, and genetic testing enabled accurate diagnosis and appropriate clinical management.</p><p><strong>Conclusion: </strong>ADPKD associated with pathogenic <i>PKD2</i> variants may present with hepatic cystic lesions that resemble Caroli disease. This case series underscores the importance of combining imaging studies with genetic testing in the differential diagnosis of hereditary cystic hepatobiliary disorders and supports the role of molecular diagnostics in guiding clinical management and genetic counseling.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Longitudinal changes in proteinuria and kidney function during standard-dose Nefecon treatment in IgA nephropathy: A real-world cohort study.","authors":"Yuhe Yin, Haowen Lin, Qianrong Xiao, Shuman Li, Lixia Xu, Jianchao Ma, Shuangxin Liu, Yiming Tao","doi":"10.5414/CN112185","DOIUrl":"https://doi.org/10.5414/CN112185","url":null,"abstract":"<p><strong>Background: </strong>Real-world evidence regarding longitudinal changes in proteinuria and kidney function during standard-dose Nefecon treatment in IgA nephropathy remains limited. This study evaluated longitudinal changes in proteinuria, kidney function, and safety during Nefecon 16 mg/day treatment in routine clinical practice.</p><p><strong>Materials and methods: </strong>This retrospective cohort study screened 256 patients with IgA nephropathy treated with Nefecon. Patients receiving standard-dose Nefecon 16 mg/day for at least 3 months with available baseline and follow-up efficacy data were included. Only measurements obtained during standard-dose treatment were analyzed. Longitudinal changes in natural logarithm-transformed urine protein-to-creatinine ratio (lnUPCR) and estimated glomerular filtration rate (eGFR) were evaluated using linear mixed-effects models adjusted for age, sex, baseline lnUPCR, baseline eGFR, and time-updated renin-angiotensin system (RAS) inhibitor and sodium-glucose cotransporter 2 (SGLT2) inhibitor use.</p><p><strong>Results: </strong>A total of 125 patients were included. Median baseline urine protein-to-creatinine ratio (UPCR) was 846.57 mg/g, and median eGFR was 54.08 mL/min/1.73m<sup>2</sup>. Compared with baseline, lnUPCR was significantly lower at 3 months (β = -0.337, 95% confidence interval (CI): -0.483 to -0.191), 6 months (β = -0.426, 95% CI: -0.614 to -0.237), and 9 months (β = -0.451, 95% CI: -0.680 to -0.221; all p < 0.001). Piecewise analysis showed that UPCR declined most rapidly during the first 3 months. eGFR was significantly higher at 3 and 6 months and remained numerically higher at 9 months. Baseline proteinuria significantly modified the lnUPCR trajectory. 32 patients (25.6%) experienced at least 1 adverse event.</p><p><strong>Conclusion: </strong>Patients receiving standard-dose Nefecon showed a significant reduction in proteinuria over time, mainly during the first 3 months. Further controlled studies with longer follow-up are needed to determine whether this early reduction is associated with long-term kidney function benefit.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cytokines and hematological indices as potential markers of low cardiorespiratory fitness and sarcopenia in hemodialysis patients.","authors":"Chang-Hung Kuo, Ji-Tseng Fang, Ching-Chung Hsiao, Watson Hua-Sheng Tseng, Shu-Chun Huang","doi":"10.5414/CN112058","DOIUrl":"https://doi.org/10.5414/CN112058","url":null,"abstract":"<p><strong>Aims: </strong>Patients receiving maintenance hemodialysis (HD) are prone to low cardiorespiratory fitness (CRF), reduced muscle strength, and sarcopenia - conditions that predict poor outcomes but are challenging to assess routinely. This study aimed to identify plasma inflammatory cytokines and hematological parameters associated with physical fitness impairments.</p><p><strong>Materials and methods: </strong>In this cross-sectional study, 61 HD patients and 20 healthy controls underwent cardiopulmonary exercise testing, handgrip strength (HGS) measurement, dual-energy X-ray absorptiometry, cytokine quantification, and blood counts. Low peak oxygen uptake (V̇O<sub>2</sub>) was defined as < 14 mL/kg/min; low HGS, low appendicular skeletal muscle mass index (ASMI), and sarcopenia were defined per Asian Working Group criteria. Associations were analyzed using multivariate binary logistic regression and decision trees.</p><p><strong>Results: </strong>Compared with controls, HD patients demonstrated impaired physical fitness (56% low peak V̇O<sub>2</sub>, 36% low HGS, 44% low ASMI, and 21% sarcopenia), anemia, and elevated IL-6, IL-8, and IL-10. Multivariate analysis identified that older age was associated with low peak V̇O<sub>2</sub>; elevated IL-10 (OR 7.39, p = 0.019) and lower hemoglobin with low HGS; lower BMI with low ASMI; and elevated IL-6 (OR 1.17, p = 0.005) with sarcopenia. Elevated red cell distribution width (RDW) correlated with low peak V̇O<sub>2</sub>. Decision trees combining cytokines with hematological and demographic parameters showed strong discrimination for low peak V̇O<sub>2</sub> (AUC = 0.803) and sarcopenia (AUC = 0.918).</p><p><strong>Conclusion: </strong>Elevated IL-10 was independently associated with low HGS - a novel finding - while IL-6 was associated with sarcopenia. RDW emerged as a potential CRF marker. These findings suggest that cytokine and hematological profiling may hold future value for early screening of physical fitness decline in HD patients, pending external validation.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sherif Elbaz, Desika Rocha, Alejandro Best, Jose Valdes, Sridhar R Allam
{"title":"Early recurrence of ANCA-associated vasculitis within one month of kidney transplantation.","authors":"Sherif Elbaz, Desika Rocha, Alejandro Best, Jose Valdes, Sridhar R Allam","doi":"10.5414/CN112153","DOIUrl":"https://doi.org/10.5414/CN112153","url":null,"abstract":"<p><p>Recurrence of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) after kidney transplantation is relatively uncommon due to modern immunosuppressive regimens, with early recurrence being particularly rare. We present the case of a 70-year-old woman with end-stage kidney disease of uncertain etiology who developed a biopsy-proven recurrence of pauci-immune crescentic glomerulonephritis within 1 month of receiving a deceased donor kidney transplant. Her initial allograft function was excellent but was followed by a rapid rise in serum creatinine, microscopic hematuria, and proteinuria by post-operative day 20. Serology confirmed a high p-ANCA titer. She was treated with pulse steroids and rituximab, with subsequent stabilization of her kidney function. This case highlights that AAV can recur very early in the post-transplant period and underscores the critical need to maintain a high index of suspicion for recurrent or de novo pauci-immune glomerulonephritis in transplant recipients with early allograft dysfunction, especially when the cause of their native kidney disease is unclear.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marie Vangstad, Ragnhild Louise Ervik, Anne Kristine Gulsvik, Fredrik Barth Brekke, Omar Ahmed Akkouh, Jon Arne Kro Birkeland, Dag Jacobsen, Mari Asphjell Bjornaas
{"title":"Clinical course of rhabdomyolysis by etiology: Findings from a prospective cohort study.","authors":"Marie Vangstad, Ragnhild Louise Ervik, Anne Kristine Gulsvik, Fredrik Barth Brekke, Omar Ahmed Akkouh, Jon Arne Kro Birkeland, Dag Jacobsen, Mari Asphjell Bjornaas","doi":"10.5414/CN112176","DOIUrl":"https://doi.org/10.5414/CN112176","url":null,"abstract":"<p><strong>Background: </strong>Rhabdomyolysis is a complex syndrome with varying severity. Few studies compare outcomes by etiology, and prospective data are limited. We aimed to assess whether the clinical course of rhabdomyolysis differs according to etiology and whether this may aid early risk stratification.</p><p><strong>Materials and methods: </strong>In this prospective multicenter cohort study, 310 adults with creatine kinase ≥ 5,000 U/L and/or myoglobin ≥ 1,000 ng/mL were included. Muscle injury was categorized as traumatic or non-traumatic; the latter further divided into exertional and non-exertional. Primary outcomes were acute kidney injury (AKI), kidney function after 3 months, and in-hospital mortality.</p><p><strong>Results: </strong>AKI occurred in 108 (35%) patients: 82 (60%) in the non-exertional group, 21 (55%) in the traumatic group, and 5 (4%) in the exertional group. The odds of AKI were higher in the non-exertional (OR 39, 95% CI: 13 - 116) and traumatic groups (OR 29, 95% CI: 9 - 89) compared to the exertional group. Stage III AKI occurred in 36 (12%) patients, mainly in the non-exertional group, with increased odds. No significant difference was found between the traumatic and exertional groups. Reduced kidney function after 3 months was observed in 3 patients - 2 in the non-exertional group and 1 in the traumatic group. Seven (2%) patients died, all in the non-exertional group.</p><p><strong>Conclusion: </strong>The non-exertional group was associated with the highest risk, followed by the traumatic group, while exertional rhabdomyolysis generally had a milder course. Etiology may help identify patients at increased risk and support early clinical risk stratification.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Associations of base excess and alactic base excess with KDIGO stage 2 - 3 acute kidney injury in patients with acute ischemic stroke.","authors":"Jieli Wang, Zhenhua Xi, Weiliang Shi","doi":"10.5414/CN112097","DOIUrl":"https://doi.org/10.5414/CN112097","url":null,"abstract":"<p><strong>Purpose: </strong>To identify the associations of base excess (BE) and alactic base excess (aBE) with KDIGO stage 2 - 3 acute kidney injury (AKI) in patients with acute ischemic stroke (AIS).</p><p><strong>Materials and methods: </strong>In this cohort study, 1,377 adult patients with AIS were identified from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. A univariable logistic regression model was used to explore the associations of all variables with KDIGO stage 2 - 3 AKI during the ICU stay of patients. Confounding factors were screened using bidirectional stepwise regression. Subgroup analysis was stratified based on age, Glasgow Coma Scale (GCS), Sequential Organ Failure Assessment (SOFA), and comorbidities. Forest plot was plotted to identify the associations of BE and aBE with KDIGO stage 2 - 3 AKI in AIS patients in different subgroups. Restricted cubic spline (RCS) was plotted.</p><p><strong>Results: </strong>A total of 1,377 participants were included, of whom 680 developed KDIGO stage 2 - 3 AKI during their ICU stay. After adjusting for covariates including SOFA, sodium, anticoagulants, furosemide, and aspirin, we found that the association between BE < -5.124 mmol/L and KDIGO stage 2 - 3 AKI was significant (OR = 1.51, 95% CI: 1.05 - 2.16). As for aBE, we observed that aBE < -3.444 mmol/L might be related to KDIGO stage 2 - 3 AKI (OR = 1.57, 95% CI: 1.12 - 2.20). In the adjusted model, aBE < -3.444 mmol/L was associated with elevated OR of KDIGO stage 2 - 3 AKI in AIS patients (OR = 1.43, 95% CI: 1.00 - 2.04). RCS revealed the non-liner associations of BE and aBE with KDIGO stage 2 - 3 AKI in AIS patients.</p><p><strong>Conclusion: </strong>Low BE or aBE were associated with an increased risk of KDIGO stage 2 - 3 AKI in patients with AIS.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Association of IL-8 rs4073 -251T>A gene polymorphism with diabetic nephropathy in patients with type 2 diabetes mellitus.","authors":"Idris Kurt, Arzu Ay, Ayten Ustundag, İlhan Kurultak, Sedat Üstündağ","doi":"10.5414/CN112095","DOIUrl":"https://doi.org/10.5414/CN112095","url":null,"abstract":"<p><strong>Background: </strong>Diabetic nephropathy (DN) is one of the most common microvascular complications of type 2 diabetes mellitus (T2DM) and a leading cause of chronic kidney disease worldwide. Inflammatory pathways play a key role in the pathogenesis and progression of DN. Interleukin-8 (IL-8), a pro-inflammatory cytokine involved in leukocyte recruitment and activation, has been associated with renal inflammation and albuminuria. However, the contribution of IL-8 gene polymorphisms to susceptibility and progression of DN remains unclear.</p><p><strong>Materials and methods: </strong>This cross-sectional case-control study included 138 patients with T2DM and 138 age- and sex-matched healthy controls. Diabetic patients were stratified according to the presence of DN based on urinary albumin excretion and diabetic retinopathy. Genomic DNA was isolated from peripheral blood samples, and the IL-8 rs4073 -251T>A polymorphism was determined using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Genotype and allele frequencies were compared between groups, and clinical and laboratory parameters were evaluated according to genotype status.</p><p><strong>Results: </strong>Genotype distributions of the IL-8 rs4073 -251T>A polymorphism were similar between T2DM patients and controls, suggesting no association with the development of T2DM. Among diabetic patients, however, the AA genotype was detected only in individuals without nephropathy and was absent in both latent and overt DN groups. Patients lacking the AA genotype demonstrated higher urinary albumin excretion and a greater frequency of nephropathy progression. DN patients also exhibited longer diabetes duration, poorer glycemic control, impaired renal function, and elevated inflammatory markers compared with patients without nephropathy. Additionally, an inverse relationship between the presence of the A allele and leukocyte and neutrophil counts was observed.</p><p><strong>Conclusion: </strong>The IL-8 rs4073 -251T>A polymorphism does not appear to influence susceptibility to T2DM; however, the presence of the A allele may exert a protective effect against the development of diabetic nephropathy. This protective effect may be mediated through modulation of inflammatory pathways, as suggested by the inverse association between the A allele and inflammatory cell counts. Larger multicenter studies are required to confirm these findings.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comprehensive look at emergency admissions in renal care (CLEAR): A study from a tertiary care hospital in South India.","authors":"Manjusha Yadla, Meliath Babu Nayana","doi":"10.5414/CN111937","DOIUrl":"10.5414/CN111937","url":null,"abstract":"<p><p>With the increasing number of chronic kidney disease (CKD) patients, emergency renal care admissions are on the rise. Non-availability of structured emergency dialysis services at primary/secondary health care levels is the reason why a majority of patients seek emergency care in tertiary care settings. In addition, acute kidney injury (AKI) due to sepsis, poisoning, and obstruction still remains one of the major causes of emergency kidney care services.</p><p><strong>Aim: </strong>Our aim was to analyze the patterns and outcomes of emergency kidney care admissions in a tertiary care setting.</p><p><strong>Materials and methods: </strong>A case record study of patients admitted over a duration of 3 years to the emergency kidney care department was done at our setting, a tertiary care public sector teaching hospital.</p><p><strong>Results: </strong>Of 4,700 admissions, 3,700 case records were analyzed. The majority (> 50%) were dialysis patients with fluid overload (pulmonary edema), sepsis, and catheter-related infections. In dialysis CKD patients, the predominant cause of seeking emergency care was fluid overload (40%) and sepsis (21%), whereas in AKI it was sepsis (25%) and obstructive uropathy (11%).</p><p><strong>Conclusion: </strong>Half the admissions to emergency kidney care comprised dialysis patients. Important causes for seeking emergency care were pulmonary edema and sepsis. A high mortality rate was observed in those with high Sequential Organ Failure Assessment (SOFA) scores upon admission.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149104968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Wei Sun, Terri Madison, Li Yang, Elizabeth Liang, Giancarlo Pesce, Sarah Zaidi, Vishnudas Sarda, Ramin Tolouian, Christopher Ngai
{"title":"An observational study of patients receiving delayed-release budesonide (Nefecon) for immunoglobulin A nephropathy in the United States: A case series of Asian-American patients.","authors":"Wei Sun, Terri Madison, Li Yang, Elizabeth Liang, Giancarlo Pesce, Sarah Zaidi, Vishnudas Sarda, Ramin Tolouian, Christopher Ngai","doi":"10.5414/CN112036","DOIUrl":"10.5414/CN112036","url":null,"abstract":"<p><strong>Introduction: </strong>IgA nephropathy (IgAN) is a leading cause of glomerulonephritis worldwide with variability by race and ethnicity. This study aimed to provide insights on the treatment journey and clinical outcomes in Asian-American patients with IgAN treated with delayed-release budesonide (Nefecon) in a real-world setting.</p><p><strong>Materials and methods: </strong>In this observational cohort study, a total of 45 consecutive patients with IgAN treated with Nefecon at Chinatown Kidney Care (CKC) (New York, NY, USA) were included. Study outcomes included treatment patterns and clinical outcomes (time to kidney failure, estimated glomerular filtration rate (eGFR), and urine protein-to-creatinine ratio (UPCR)). All variables were summarized descriptively. Subgroup analyses were performed among patients who were treated for ≥ 9 months vs. those treated for < 9 months.</p><p><strong>Results: </strong>Overall, after 9 months of treatment, eGFR remained stable and UPCR decreased by an average of 19%. Improved clinical outcomes were reported among those who were treated for ≥ 9 months (preservation of eGFR and 26% reduction in UPCR) compared with those treated for < 9 months (decline in eGFR and ~ 3% reduction in UPCR). Nefecon was well tolerated with no severe or unexpected adverse events reported.</p><p><strong>Conclusion: </strong>Real-world IgA nephropathy treatment-associated outcomes with Nefecon in Asian-American patients for proteinuria and kidney function were consistent with those observed in the NefIgArd clinical trial. The reduction in proteinuria and improvement in kidney function was greater in patients who completed the 9-month course of therapy. These findings reveal an opportunity for further education among nephrologists regarding the recommended duration of treatment with Nefecon.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":"276-285"},"PeriodicalIF":0.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13621273/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148758105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}